A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders

Noha F. Minshawi, Logan K. Wink, Rebecca Shaffer, Martin H. Plawecki, David J. Posey, Hai Liu, Sarah Hurwitz, Christopher J. McDougle, Naomi Swiezy, Craig A. Erickson

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Researchers have demonstrated that d-cycloserine (DCS) can enhance the effects of behavioral interventions in adults with anxiety and enhances prosocial behavior in animal models of autism spectrum disorders (ASD). This study extended upon this background by combining DCS with behavioral social skills therapy in youth with ASD to assess its impact on the core social deficits of ASD. We hypothesized that DCS used in combination with social skills training would enhance the acquisition of social skills in children with ASD. Methods: A 10-week, double-blind, placebo-controlled trial of DCS (50 mg) given 30 min prior to weekly group social skills training was conducted at two sites. Children with ASD were randomized to receive 10 weeks (10 doses) of DCS or placebo in a 1:1 ratio. Results: No statistically significant difference attributable to drug treatment was observed in the change scores for the primary outcome measure, the Social Responsiveness Scale (SRS), total score (p = 0.45), or on secondary outcome measures. Conclusions: The results of this trial demonstrated no drug-related short-term improvement on the primary outcome measure, or any of the secondary outcome measures. However, an overall significant improvement in SRS total raw score was observed from baseline to end of treatment for the entire group of children with ASD. This suggests a need to further study the efficacy of the social skills training protocol. Limitations to the current study and areas for future research are discussed.

Original languageEnglish (US)
Article number2
JournalMolecular Autism
Volume7
Issue number1
DOIs
StatePublished - Jan 14 2016

Fingerprint

Cycloserine
Randomized Controlled Trials
Placebos
Outcome Assessment (Health Care)
antineoplaston A10
Pharmaceutical Preparations
Autism Spectrum Disorder
Social Skills
Therapeutics
Anxiety
Animal Models
Research Personnel

Keywords

  • Autism spectrum disorders
  • d-cycloserine
  • Social deficits
  • Social skills training

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental Neuroscience
  • Developmental Biology
  • Molecular Biology

Cite this

Minshawi, N. F., Wink, L. K., Shaffer, R., Plawecki, M. H., Posey, D. J., Liu, H., ... Erickson, C. A. (2016). A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders. Molecular Autism, 7(1), [2]. https://doi.org/10.1186/s13229-015-0062-8

A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders. / Minshawi, Noha F.; Wink, Logan K.; Shaffer, Rebecca; Plawecki, Martin H.; Posey, David J.; Liu, Hai; Hurwitz, Sarah; McDougle, Christopher J.; Swiezy, Naomi; Erickson, Craig A.

In: Molecular Autism, Vol. 7, No. 1, 2, 14.01.2016.

Research output: Contribution to journalArticle

Minshawi, NF, Wink, LK, Shaffer, R, Plawecki, MH, Posey, DJ, Liu, H, Hurwitz, S, McDougle, CJ, Swiezy, N & Erickson, CA 2016, 'A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders', Molecular Autism, vol. 7, no. 1, 2. https://doi.org/10.1186/s13229-015-0062-8
Minshawi, Noha F. ; Wink, Logan K. ; Shaffer, Rebecca ; Plawecki, Martin H. ; Posey, David J. ; Liu, Hai ; Hurwitz, Sarah ; McDougle, Christopher J. ; Swiezy, Naomi ; Erickson, Craig A. / A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders. In: Molecular Autism. 2016 ; Vol. 7, No. 1.
@article{0252f109454f4fec99207b8d270fbc28,
title = "A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders",
abstract = "Background: Researchers have demonstrated that d-cycloserine (DCS) can enhance the effects of behavioral interventions in adults with anxiety and enhances prosocial behavior in animal models of autism spectrum disorders (ASD). This study extended upon this background by combining DCS with behavioral social skills therapy in youth with ASD to assess its impact on the core social deficits of ASD. We hypothesized that DCS used in combination with social skills training would enhance the acquisition of social skills in children with ASD. Methods: A 10-week, double-blind, placebo-controlled trial of DCS (50 mg) given 30 min prior to weekly group social skills training was conducted at two sites. Children with ASD were randomized to receive 10 weeks (10 doses) of DCS or placebo in a 1:1 ratio. Results: No statistically significant difference attributable to drug treatment was observed in the change scores for the primary outcome measure, the Social Responsiveness Scale (SRS), total score (p = 0.45), or on secondary outcome measures. Conclusions: The results of this trial demonstrated no drug-related short-term improvement on the primary outcome measure, or any of the secondary outcome measures. However, an overall significant improvement in SRS total raw score was observed from baseline to end of treatment for the entire group of children with ASD. This suggests a need to further study the efficacy of the social skills training protocol. Limitations to the current study and areas for future research are discussed.",
keywords = "Autism spectrum disorders, d-cycloserine, Social deficits, Social skills training",
author = "Minshawi, {Noha F.} and Wink, {Logan K.} and Rebecca Shaffer and Plawecki, {Martin H.} and Posey, {David J.} and Hai Liu and Sarah Hurwitz and McDougle, {Christopher J.} and Naomi Swiezy and Erickson, {Craig A.}",
year = "2016",
month = "1",
day = "14",
doi = "10.1186/s13229-015-0062-8",
language = "English (US)",
volume = "7",
journal = "Molecular Autism",
issn = "2040-2392",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders

AU - Minshawi, Noha F.

AU - Wink, Logan K.

AU - Shaffer, Rebecca

AU - Plawecki, Martin H.

AU - Posey, David J.

AU - Liu, Hai

AU - Hurwitz, Sarah

AU - McDougle, Christopher J.

AU - Swiezy, Naomi

AU - Erickson, Craig A.

PY - 2016/1/14

Y1 - 2016/1/14

N2 - Background: Researchers have demonstrated that d-cycloserine (DCS) can enhance the effects of behavioral interventions in adults with anxiety and enhances prosocial behavior in animal models of autism spectrum disorders (ASD). This study extended upon this background by combining DCS with behavioral social skills therapy in youth with ASD to assess its impact on the core social deficits of ASD. We hypothesized that DCS used in combination with social skills training would enhance the acquisition of social skills in children with ASD. Methods: A 10-week, double-blind, placebo-controlled trial of DCS (50 mg) given 30 min prior to weekly group social skills training was conducted at two sites. Children with ASD were randomized to receive 10 weeks (10 doses) of DCS or placebo in a 1:1 ratio. Results: No statistically significant difference attributable to drug treatment was observed in the change scores for the primary outcome measure, the Social Responsiveness Scale (SRS), total score (p = 0.45), or on secondary outcome measures. Conclusions: The results of this trial demonstrated no drug-related short-term improvement on the primary outcome measure, or any of the secondary outcome measures. However, an overall significant improvement in SRS total raw score was observed from baseline to end of treatment for the entire group of children with ASD. This suggests a need to further study the efficacy of the social skills training protocol. Limitations to the current study and areas for future research are discussed.

AB - Background: Researchers have demonstrated that d-cycloserine (DCS) can enhance the effects of behavioral interventions in adults with anxiety and enhances prosocial behavior in animal models of autism spectrum disorders (ASD). This study extended upon this background by combining DCS with behavioral social skills therapy in youth with ASD to assess its impact on the core social deficits of ASD. We hypothesized that DCS used in combination with social skills training would enhance the acquisition of social skills in children with ASD. Methods: A 10-week, double-blind, placebo-controlled trial of DCS (50 mg) given 30 min prior to weekly group social skills training was conducted at two sites. Children with ASD were randomized to receive 10 weeks (10 doses) of DCS or placebo in a 1:1 ratio. Results: No statistically significant difference attributable to drug treatment was observed in the change scores for the primary outcome measure, the Social Responsiveness Scale (SRS), total score (p = 0.45), or on secondary outcome measures. Conclusions: The results of this trial demonstrated no drug-related short-term improvement on the primary outcome measure, or any of the secondary outcome measures. However, an overall significant improvement in SRS total raw score was observed from baseline to end of treatment for the entire group of children with ASD. This suggests a need to further study the efficacy of the social skills training protocol. Limitations to the current study and areas for future research are discussed.

KW - Autism spectrum disorders

KW - d-cycloserine

KW - Social deficits

KW - Social skills training

UR - http://www.scopus.com/inward/record.url?scp=84954127959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954127959&partnerID=8YFLogxK

U2 - 10.1186/s13229-015-0062-8

DO - 10.1186/s13229-015-0062-8

M3 - Article

VL - 7

JO - Molecular Autism

JF - Molecular Autism

SN - 2040-2392

IS - 1

M1 - 2

ER -